🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul D. Smith

Epworth Hospital

ORCID: 0000-0002-2812-5978
MedicineComputer ScienceBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma”.

Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

Clinical Cancer Research(2013)10.1158/1078-0432.ccr-13-0842
N/A
0.614DataRank · unranked
59 citations

Aaron Kibler, Doris A. Phelps, Sagymbek Manap, Linlin Xiao, Jiayuh Lin +10 more

MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects

Nature Immunology(2020)10.1038/s41590-020-00818-9
N/A
0DataRank · unranked
181 citations

Nazli Jafarzadeh, Shannon K. Boi, Subhadip Kundu, Zhinuo Jiang, Yiping Fan +16 more

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

Cancer Research(2020)10.1158/0008-5472.can-19-3819
N/A
0DataRank · unranked
60 citations

Alexis Guernet, Maria Emanuela Cuomo, Kamrine E. Poels, Iris K. van Alderwerelt van Rosenburgh, Amy Nagelberg +19 more

Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab020
N/A
0DataRank · unranked
8 citations

Alexander Coutts, Dylan Duerre, Barbara R. Tschida, Mark N. Kirstein, James Fisher +8 more

Data from Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

10.1158/1078-0432.c.6521018
N/A
0DataRank · unranked
0 citations

Aaron Kibler, Doris A. Phelps, Sagymbek Manap, Linlin Xiao, Jiayuh Lin +10 more